DNAPrint Genomics, Inc.
DNAG · OTC
9/30/2007 | 6/30/2007 | 3/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Revenue | $228 | $477 | $701 | $526 |
| % Growth | -52.3% | -32% | 33.4% | – |
| Cost of Goods Sold | $234 | $391 | $515 | $345 |
| Gross Profit | -$7 | $86 | $186 | $181 |
| % Margin | -2.9% | 18% | 26.6% | 34.4% |
| R&D Expenses | $1,109 | $1,033 | $1,112 | $1,277 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $547 | $509 | $521 | $646 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$3,325 | -$2,913 | -$2,892 | -$3,483 |
| Operating Expenses | -$1,669 | -$1,371 | -$1,259 | -$1,561 |
| Operating Income | $1,662 | $1,456 | $1,446 | $1,741 |
| % Margin | 730.6% | 305.3% | 206.2% | 331.3% |
| Other Income/Exp. Net | -$1,662 | -$1,456 | -$1,446 | -$1,741 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,881 | -$1,697 | $2,888 | -$3,861 |
| % Margin | -826.7% | -355.8% | 412% | -734.5% |
| EPS | -0.003 | -0.003 | 0.01 | -0.009 |
| % Growth | 0% | -130% | 211.1% | – |
| EPS Diluted | -0.003 | -0.003 | 0.01 | -0.009 |
| Weighted Avg Shares Out | 630,330 | 563,965 | 495,587 | 430,413 |
| Weighted Avg Shares Out Dil | 630,330 | 563,965 | 495,587 | 430,413 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $156 | $179 | $219 | $261 |
| EBITDA | -$1,507 | -$1,277 | -$1,014 | -$1,296 |
| % Margin | -662.2% | -267.8% | -144.7% | -246.6% |